Tech Company Financing Transactions
EvoEndo Funding Round
EvoEndo closed a $8.4 million Series A financing round on 4/19/2022. Investors included TLP, private investors and Sunshine Foundation.
Transaction Overview
Company Name
Announced On
4/19/2022
Transaction Type
Venture Equity
Amount
$8,400,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the financing will be used to support the initial commercial launch of the EvoEndo® Single-Use Endoscopy System by hiring additional personnel and growing inventory capacity.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9615 E. County Line Ste B-647
Centennial, CO 80112
USA
Centennial, CO 80112
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
EvoEndo is making pediatric unsedated transnasal endoscopy a reality. EvoEndo is driving the evolution of innovative pediatric endoscopy by allowing diagnostic upper endoscopies to be performed safely and quickly in children without the use of general anesthesia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Heather Underwood
Chief Financial Officer
Carrie Showalter
Chief Medical Officer
Joel Friedlander
Co-Founder
Emily DeBoer
Co-Founder
Robin Deterding
Co-Founder
Jeremy Prager
VP - Operations
Derek Southard
Browse more venture capital transactions:
Prev: 4/19/2022: U.S. Integrity venture capital transaction
Next: 4/19/2022: Free Market Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs